Skip to main content

HEALTH

  • Hyland’s to ‘Defend’ adults from colds with new line

    NEW YORK — Hyland’s will attempt to parlay its success across its 4 Kids line of homeopathic solutions into the adult section with its recent launch of the Hyland’s Defend line. “We are seeing tremendous growth in our cold and cough 4 Kids,” noted Jay Borneman, chairman and CEO at Hyland’s. 


  • Q&A: Help is on the way

    OTC supplier Help Remedies is trying to break through the brands at Duane Reade and Target. Drug Store News sat down with Help visionary and CEO Richard Fine to discuss branding.


    Drug Store News: What is the Help Remedies proposition?


  • Raising the bar in 
nutritional snacking

    
The snack is back! Judging from the amount of growth within the 
nutritional bar category in the past year, snacking is definitely en vogue. 
Incremental annual sales totaled $117.5 million across food, drug and mass retailers, with the exception of Walmart, according to SymphonyIRI Group. Out of all over-the-counter growth categories for the 52 weeks ended April 17, nutritional bars as a category took in more dollars on top of what they had generated the year before than any other category, bar none. 


  • MMA Elite Series powered by MusclePharm supplements line to make debut

    DENVER — MusclePharm has introduced a sports nutrition supplements line through a licensing deal with MMA Elite of Ultimate Brand Management.

    The line, MMA Elite Series powered by MusclePharm, includes pre-workout, recovery, vitamin, protein and fat-loss products. Such retailers as Walmart, Sam's Club and Walgreens are being targeted to distribute the supplements in third quarter 2011, MusclePharm said.

    Many MusclePharm products currently are sold in GNC.

  • FDA updates ongoing safety review of Actos

    SILVER SPRING, Md. — The Food and Drug Administration on Thursday informed the public that continued use of a Type 2 diabetes treatment made by Takeda Pharmaceuticals for more than one year may be associated with an increased risk of bladder cancer.

  • Nipro, NeuroMetrix collaborate to market NC-stat DPNCheck

    WALTHAM, Mass. — Nipro Diagnostics and NeuroMetrix have teamed up to market a point-of-care test that is designed to evaluate such systemic neuropathies as diabetic peripheral neuropathy.

    Nipro and NeuroMetrix said the NC-stat DPNCheck test, developed by NeuroMetrix, could offer a cost-effective approach to detecting and monitoring DPN, which affects more than half of people with diabetes and could lead to such conditions as foot ulcers and limb amputation.

    The companies currently are evaluating opportunities for the NC-stat DPNCheck in retail medical clinics.

  • Liraglutide may prompt optimal blood-glucose levels in Type 1 diabetics

    BUFFALO, N.Y. — A popular Type 2 diabetes treatment may help Type 1 diabetics achieve control of their blood-glucose levels, according to a small, observational study conducted at the University of Buffalo.

  • CHPA praises North Carolina's passage of PSE sales blocking technology legislation

    WASHINGTON — The North Carolina legislature passed a real-time, stop-sale system, which allows law-abiding citizens to access medicines containing pseudoephedrine, while stopping sales that exceed the legal limit.

    The passage was lauded by the Consumer Healthcare Products Association.

X
This ad will auto-close in 10 seconds